SPMXF (Supermax Bhd) Cash Conversion Cycle: 50.23 (As of Mar. 2026)


SPMXF Supermax Corp Bhd SPMXF
51 GF Score
Price $0.15
GF Value $0.37
! 6 Warning Signs
View Full Analysis

What is Supermax Bhd Cash Conversion Cycle?

Supermax Bhd SPMXF 51 Cash Conversion Cycle is 50.23 as of Mar. 2026. GuruFocus rates SPMXF with a GF Score™ of 51/100 and a GF Value™ of $0.37. The stock has 6 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Supermax Bhd's Days Sales Outstanding for the three months ended in Mar. 2026 was 50.23.
Supermax Bhd's Days Inventory for the three months ended in Mar. 2026 was .
Supermax Bhd's Days Payable for the three months ended in Mar. 2026 was .
Therefore, Supermax Bhd's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2026 was 50.23.


Supermax Bhd  (OTCPK:SPMXF) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Supermax Bhd Cash Conversion Cycle Related Terms


Supermax Bhd Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Supermax Bhd's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supermax Bhd Cash Conversion Cycle Chart

Supermax Bhd Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.80 117.34 68.40 48.64 94.29

Supermax Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.32 40.42 30.40 36.30 50.23

SPMXF vs ISRG, BDX, MDLN: Cash Conversion Cycle Comparison

For the Medical Instruments & Supplies subindustry, Supermax Bhd's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supermax Bhd Cash Conversion Cycle vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Supermax Bhd's Cash Conversion Cycle falls into.


SPMXF
51GF Score
Supermax Corp Bhd SPMXF
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supermax Bhd Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Supermax Bhd's Cash Conversion Cycle for the fiscal year that ended in Jun. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=28.28+108.37-42.36
=94.29

Supermax Bhd's Cash Conversion Cycle for the quarter that ended in Mar. 2026 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=50.23+-
=50.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 50.23 mean?
Supermax Bhd (SPMXF) has a Cash Conversion Cycle of 50.23 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Supermax Bhd and its competitors.
Is Supermax Bhd's Cash Conversion Cycle too high?
Supermax Bhd's current Cash Conversion Cycle is 50.23. The Medical Devices & Instruments industry median Cash Conversion Cycle is 156.39. Supermax Bhd's value of 50.23 is 67.9% below this industry median. Overall, Supermax Bhd has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's Cash Conversion Cycle compare to ISRG and BDX?
Supermax Bhd's Cash Conversion Cycle of 50.23 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 156.39. Supermax Bhd's value of 50.23 is 67.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 156.39, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supermax Bhd's current Cash Conversion Cycle of 50.23 is 67.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Supermax Bhd and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 156.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supermax Bhd's current Cash Conversion Cycle is 50.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Supermax Bhd (SPMXF) has a current Cash Conversion Cycle of 50.23. The stock's GF Value™ is $0.37, compared to a current price of $0.15 — trading 59.5% below its estimated fair value. The current Cash Conversion Cycle is 50.23 and 67.9% below the Medical Devices & Instruments industry median of 156.39. Supermax Bhd's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Supermax Bhd (SPMXF), the current Cash Conversion Cycle is 50.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supermax Bhd (SPMXF) Overvalued in 2026?

Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued. The current stock price of $0.15 is trading 59.5% below its estimated GF Value™ of $0.37.

Key valuation signals for SPMXF:

  • Cash Conversion Cycle: 50.23
  • GF Value™: $0.37 vs. price of $0.15 (59.5% below fair value)
  • GF Score™: 51/100 with 6 warning signs
  • Industry Position: 67.9% below the Medical Devices & Instruments median

No single metric tells the full story. See the SPMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Supermax Bhd Business Description

Other Exchanges 7106:Malaysia
Address Lot 38, Putra Industrial Park, Bukit Rahman Putra, Sungai Buloh, SGR, MYS, 40160
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
51GF Score

Get the complete analysis for SPMXF

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.37
GF Value